Follow-up by one- and two-dimensional NMR of plasma from pigs with ischemia-induced acute liver failure treated with a bioartificial liver

NMR in Biomedicine

Volumn 15, Issue 6, 2002, Pages 393-403

  Tréhout, David ^a,b   Desille, Mireille ^b   Doan, Bich Thuy ^a,d   Mahler, Stephan ^b   Frémond, Benjamin ^b   Mallédant, Yannick ^b   Campion, Jean Pierre ^b   Desbois, Jeanne ^c   Beloeil, Jean Claude ^a   De Certaines, Jacques ^b   Clément, Bruno ^b  

^a CNRS   (France)

^b UNIVERSITÉ DE RENNES 1   (France)

^c ETABLISSEMENT FRANÇAIS DU SANG   (France)

^d INSTITUT DE CHIMIE DES SUBSTANCES NATURELLES   (France)

Author keywords

1D and 2D NMR spectroscopy; Acute liver failure; Bioartificial liver; Hepatic encephalopathy; Pigs

Indexed keywords

METABOLITES; NEUROLOGY; NUCLEAR MAGNETIC RESONANCE; TOXIC MATERIALS;

PLASMA COMPOUNDS;

BIOMEDICAL ENGINEERING;

ALGINIC ACID; CHOLINE; GLUTAMINE; N ACETYLGLUCOSAMINE; PYRUVIC ACID; TRIMETHYLAMINE OXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL LIVER; BIOARTIFICIAL ORGAN; BLOOD LEVEL; BRAIN EDEMA; CELL DAMAGE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEPATIC ENCEPHALOPATHY; LIVER CELL; LIVER FAILURE; LIVER ISCHEMIA; LONGITUDINAL STUDY; METABOLITE; NEUROLOGIC DISEASE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SURVIVAL; SWINE;

ACUTE DISEASE; AMINO ACIDS; ANIMALS; CARBOHYDRATES; DISEASE MODELS, ANIMAL; HEPATIC ENCEPHALOPATHY; HEPATOCYTES; ISCHEMIA; LIPOPROTEINS; LIVER; LIVER CIRCULATION; LIVER, ARTIFICIAL; MAGNETIC RESONANCE SPECTROSCOPY; SWINE;

ANIMALIA; SUS SCROFA;

EID: 0036790302     PISSN: 09523480     EISSN: None     Source Type: Journal    
DOI: 10.1002/nbm.794     Document Type: Article

References (34)

1. O'Grady JG, Portmann B, Williams R. Fulminant hepatic failure. In Diseases of the Liver 7th edn, Schiff L, Schiff ER. (eds). Lippincott: Philadelphia, PA, 1993; 1077-1090.
2. Williams R, Gimson AE. Intensive liver care and management of acute hepatic failure. Dig. Dis. Sci. 1991; 36: 820-826.
3. Hoofnagle JH, Carithers RL, Shapiro C, Ascher N. Fulminant hepatic failure: summary of a workshop. Hepatology 1995; 21: 240-252.
4. Macdonald JM, Grillo M, Schmidlin O, Tajiri DT, James TL. NMR spectroscopy and MRI investigation of a potential bioartificial liver. NMR Biomed. 1998; 11: 55-66.
5. Ascher NL, Lake JR, Emond JC, Roberts JP. Liver transplantation for fulminant hepatic failure. Arch. Surg. 1993; 128: 677-682.
6. Frémond B, Malandain C, Guyomard C, Chesné C, Guillouzo A, Campion JP. Correction of bilirubin conjugation in the Gunn rat using hepatocytes immobilized in alginate gel beads as an extracorporeal bioartificial liver. Cell. Transplant. 1993; 2: 453-460.
7. Joly A, Desjardins JF, Frémond B, Desille M, Campion JP, Mallédant Y, Lebreton Y, Semana G, Edwards-Levy F, Levy MC, Clément B. Survival, proliferation, and functions of porcine hepatocytes encapsulated in coated alginate beads: a step toward a reliable bioartificial liver. Transplantation 1997; 63: 795-803.
8. Desille M, Corcos L, L'Helgoualc'h A, Frémond B, Campion JP, Guillouzo A, Clément B. Detoxifying activity in pig livers and hepatocytes intended for xenotherapy. Transplantation 1999; 68: 1437-1443.
9. Desille M, Frémond B, Mahler S, Mallédant Y, Seguin P, Bouix A, Lebreton Y, Desbois J, Campion JP, Clément B. Improvement of the neurological status of pigs with acute liver failure by hepatocytes immobilized in alginate gel beads inoculated in an extracorporeal bioartificial liver. Transplant. Proc. 2001; 33: 1932-1934.
10. Desille M, Mahler S, Seguin P, Mallédant Y, Frémond B, Sébille V, Bouix A, Desjardins JF, Joly A, Desbois J, Lebreton Y, Campion JP, Clément B. Reduced encephalopathy in pigs with ischemia-induced acute hepatic failure treated with a bioartificial liver containing alginate entrapped hepatocytes. Crit. Care Med. 2002; 30: 658-663.
11. Bax A, Davis D. Assignment of complex 1 H NMR spectra via two-dimensional Hartmann-Hahn spectroscopy. J. Am. Chem. Soc. 1985; 107: 2820-2821.
12. Schleucher J, Schwendinger M, Sattler M, Schmidt P, Schedletzky O, Glaser SJ, Sorensen OW, Griesinger C. A general enhancement scheme in heteronuclear multidimensional NMR employing pulsed field gradients. J. Biomol. NMR 1994; 4: 301-306.
13. Zieve L. Pathogenesis of hepatic encephalopathy. Metab. Brain. Dis. 1987; 2: 147-165.
14. Cooper AJL, Plum F. Biochemistry and physiology of brain ammonia. Physiol. Rev. 1987; 67: 440-519.
15. Mousseau DD, Butterworth RF. Current theories on the pathogenesis of hepatic encephalopathy. Proc. Soc. Exp. Biol. Med. 1994; 206: 329-344.
16. Meijer AJ, Lamers WH, Chamuleau RAFM. Nitrogen metabolism and ornithine cycle function. Physiol. Rev. 1990; 70: 701-748.
17. Dejong CH, Kampman MT, Deutz NE, Soeters PB. Cerebral cortex ammonia and glutamine metabolism during liver insufficiency-induced hyperammonemia in the rat. J. Neurochem. 1992; 59: 1071-1079.
18. Dejong CH, Deutz NE, Soeters PB. Cerebral cortex ammonemia and glutamine metabolism in two rat models of chronic liver insufficiency-induced hyperammonemia: influence of pair-feeding. J. Neurochem. 1993; 60: 1047-1067.
19. Laubenberger J, Haussinger D, Bayer S, Gufler H, Henning J, Langer M. Proton magnetic resonance spectroscopy of the brain in symptomatic and asymptomatic patients with liver cirrhosis. Gastroenterology 1997; 112: 1610-1616.
20. Taylor-Robinson SD, Sargentoni J, Marcus CD, Morgan MY, Bryant DJ. Regional variations in cerebral proton spectroscopy in patients with chronic hepatic encephalopathy. Metab. Brain Disord. 1994; 9: 347-359.
21. 1H MR spectroscopy and neuropsychologic status of patients with hepatic encephalopathy. Am. J. Roentgenol. 1998; 171: 1123-1130.
22. Geissler A, Lock G, Frund R, Held P, Hollerbach S, Andus T, Scholmerich J, Feuerbach S, Holstege A. Cerebral abnormalities in patients with cirrhosis detected by proton magnetic resonance spectroscopy and magnetic resonance imaging. Hepatology 1997; 25: 48-54.
23. 1H NMR spectroscopy in patients with chronic hepatic encephalopathy. Analysis of changes in cerebral glutamine, choline and inositols. NMR Biomed. 1991; 4: 109-116.
24. Kreis R, Ross BD, Farrow NA, Ackerman Z. Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy. Radiology 1992; 182: 19-27.
25. Ross BD, Jacobson S, Villamil F, Korula J, Kreis R, Ernst T, Shonk T, Moats RA. Subclinical hepatic encephalopathy: proton MR spectroscopic abnormalities. Radiology 1994; 193: 457-463.
26. 1H-NMR spectroscopy and biochemical investigation. Hepatology 1990; 12: 281-190.
27. Richards TL. Proton MR in multiple sclerosis: value in establishing diagnosis, monitoring progression, and evaluating therapy. Am. J. Roentgenol. 1991; 157: 1073-1078.
28. 1H magnetic resonance spectroscopy. Surg. Neurol. 1995; 44: 137-144
29. Galea E, Estrada C. Ouabain-sensitive choline transport system in capillaries isolated from bovine brain. J. Neurochem. 1992; 59: 936-941.
30. Rao VL, Therrien G, Butterworth RF. Choline acetyltransferase and acetylcholinesterase activities are unchanged in brain in human and experimental portal-systemic encephalopathy. Metab. Brain Disord. 1994; 9: 401-407.
31. Somero GN. From dogfish to dogs: Trimethylamines protect proteins from urea. News Physiol. Sci. 1986; 1: 9-12.
32. . Le Moyec L, Pruna A, Eugene M, Bedrossian J, Idatte JM, Huneau JF, Tome D. Proton nuclear magnetic resonance spectroscopy of urine and plasma in renal transplantation follow-up. Nephron 1993; 65: 433-439.
33. Bell JD, Lee JA, Sadler PJ, Wilkie DR, Woodman RH. Nuclear magnetic resonance studies of blood plasma and urine from subjects with chronic renal failure: identification of trimethlamine-N-oxide. Biochem. Biophys. Acta. 1991; 1096: 101-107.
34. McCashland TM, Shaw BW Jr, Tape E. The American experience with transplantation for acute liver failure. Semin. Liver Dis. 1996; 16: 427-433.